The estimated Net Worth of Johonna Marie Pelletier is at least $4.64 Million dollars as of 28 April 2023. Johonna Pelletier owns over 24,017 units of Conmed stock worth over $96,549 and over the last 6 years Johonna sold CNMD stock worth over $4,542,238.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Johonna Pelletier CNMD stock SEC Form 4 insiders trading
Johonna has made over 15 trades of the Conmed stock since 2018, according to the Form 4 filled with the SEC. Most recently Johonna sold 24,017 units of CNMD stock worth $3,035,268 on 28 April 2023.
The largest trade Johonna's ever made was selling 24,017 units of Conmed stock on 28 April 2023 worth over $3,035,268. On average, Johonna trades about 3,645 units every 100 days since 2018. As of 28 April 2023 Johonna still owns at least 1,317 units of Conmed stock.
You can see the complete history of Johonna Pelletier stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Johonna Pelletier's mailing address?
Johonna's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Insiders trading at Conmed
Over the last 5 years, insiders at Conmed have traded over $0 worth of Conmed stock. The most active insiders traders include Curt R Hartman, Daniel S Jonas und Terence M Berge. On average, Conmed executives and independent directors trade stock every 0 days with the average trade being worth of $58,501. The most recent stock trade was executed by John Jed Kennedy on 28 February 2020, trading 1,575 units of CNMD stock currently worth $115,463.
What does Conmed do?
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
What does Conmed's logo look like?
Complete history of Johonna Pelletier stock trades at Conmed und Conmed
Conmed executives and stock owners
Conmed executives and other stock owners filed with the SEC include:
-
Curt R. Hartman,
Chairman, CEO & Pres -
Patrick J. Beyer,
Pres of International & Global Orthopedics -
Todd W. Garner,
Exec. VP & CFO -
Daniel S. Jonas Esq.,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Stanley W. Peters III,
VP & GM of U.S. Advanced Surgical -
John E. Kennedy,
Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service -
David R. Murray,
Pres of ConMed Electrosurgery -
Shanna L. Cotti-Osmanski,
Exec. VP of Information Technology & CIO -
Heather L. Cohen,
Exec. VP of HR -
Peter K. Shagory,
Exec. VP of Strategy & Corp. Devel. -
Daniel S. Jonas,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Terence M Berge,
VP-Corporate Controller -
Pat Beyer,
President - International -
Heather L Cohen,
EVP CORP HR -
Nathan Folkert,
VP GM Orthopedics -
Todd W Garner,
Executive Vice President & CFO -
Daniel S Jonas,
EVP Legal Affairs,Gen. Counsel -
Johonna Marie Pelletier,
Treasurer and VP, Tax -
Wilfredo Ruiz Caban,
EVP QA, RA and Operations -
Curt R Hartman,
President & CEO -
Stanley W Iii Peters,
VP GM Advanced Surgery -
Peter K Shagory,
EVP, STRAT & CORP DEVT -
John Jed Kennedy,
VP GM CET